Solid Biosciences Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Short Interest Update
Article By: Bespoke Investment Group
Wednesday, March 10, 2021 1:14 PM EDT
Short interest numbers as of the end of February were released yesterday. In aggregate across all Russell 3,000 stocks, short interest as a percent of float came in at 3.21%, down from 3.6% at the start of the year.
In this article: DDS, GEO, GME, LGND, WKHS, SLDB, BIGC, KYMR, ASO
Read
Stock Charts To Watch - Wednesday December 30
Video By: Harry Boxer
Wednesday, December 30, 2020 10:14 PM EDT
Bilibili Inc. on Wednesday exploded 11.90, or 14.43%, to 94.35, with a session high of 9.6 million shares traded. It moved up another 2.45 to 96.80 in after-hours.
In this video: FCX, CELH, VUZI, SLDB, BILI
Watch
3 Promising Gene Therapy Stocks
Article By: Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Read
Should You Buy Biotech IPOs?
Article By: Marc Lichtenfeld
Monday, September 17, 2018 7:52 PM EDT
Biotech is arguably the most exciting sector to invest in. This year, the NYSE Arca Biotechnology Index has more than doubled the S&P 500’s 14.6% total return with a 32.5% gain.
In this article: PTIE, LLY, ECYT, SLDB, SRRK, SURF, NTGN, VCNX, RGEN, NTLA
Read
3 Gene Therapy Stocks Investors Can Bet On In Rest Of 2018
Article By: Zacks Investment Research
Friday, July 13, 2018 3:05 AM EDT
Innovation holds the key in the pharma/biotech sector and most companies have been diverting their resources to develop gene therapy candidates in their goal of finding a cure for difficult and incurable diseases.
In this article: BOLD, QURE, AXON Also: NVS, PFE, SLDB
Read

Latest Tweets for $SLDB

No tweets yet!

PARTNER HEADLINES